REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE.

No abstract is available for this paper.

• Publication year

  1963

• Venue

  Annals of Internal Medicine

• Publication date

  1963-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.7326/0003-4819-59-4-477PMID 14067470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

  1963cited by this paper
• Cataracts in patients treated with triparanol.

  1962cited by this paper
• Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

  1962cited by this paper
• Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate

  1962cited by this paper
• The specific assay of Prower-Stuart factor and factor VII.

  1961cited by this paper
• EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN.

  1961cited by this paper
• Serum lipids, hypertension and coronary artery disease.

  1961cited by this paper
• Changes in serum lipids and urinary ketosteroids during oral and intramuscular administration of androsterone.

  1961cited by this paper
• Cutaneous side effects from use of triparanol (MER-29): preliminary data on ichthyosis and loss of hair.

  1961cited by this paper
• Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and man treated with MER-29.

  1960cited by this paper
• Benzmalecene: inhibition of cholesterol biosynthesis and hypocholesteremic effect in rats.

  1960cited by this paper
• Hypocholesteremic Effect in Man of Benzmalecene

  1960cited by this paper
• Hypocholesterolemic effects of N-(1-methyl-2,3-di-p-chlorophenylpropyl)-maleamic acid in hyperlipemic and normolipemic man.

  1960cited by this paper
• Thyroid-androgen interrelations and the hypocholesteremic effect of androsterone.

  1959cited by this paper
• Determination of glycerides in blood serum.

  1959cited by this paper
• Failure of Alpha‐Phenylbutyrate and Beta‐Phenylvalerate in Treatment of Hypercholesterolemia

  1957cited by this paper
• Micromethod for the direct determination of serum triglycerides.

  1957cited by this paper
• A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

  1957cited by this paper
• Inhibition of Lipid Synthesis by Alpha-Phenyl-N-Butyrate and Related Compounds

  1955cited by this paper
• The determination of total lipides in blood serum.

  1955cited by this paper
• [Therapeutic study of a synthetic hypocholesterolemic agent: phenyl-ethyl-acetic acid].

  1954cited by this paper
• [Synthesis of some alpha derivatives of isobutyric acid].

  1954cited by this paper
• A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

  1952cited by this paper
• Regression of lesions in canine arteriosclerosis.

  1951cited by this paper
• Mortality from circulatory diseases in Norway 1940-1945.

  1951cited by this paper
• A method for the rapid determination of alkaline phosphates with five cubic millimeters of serum.

  1946cited by this paper
• THE EFFECT OF THERMAL ENVIRONMENT ON THE MORPHOLOGY OF THE THYROID AND ADRENAL CORTICAL GLANDS IN THE ALBINO RAT1

  1941cited by this paper
• A MICROMETHOD FOR THE DETERMINATION OF FREE AND COMBINED CHOLESTEROL

  1934cited by this paper
• Pathways to Blood Coagulation Product I Formation

  year unknowncited by this paper

• Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores

  2023cites this paper
• The Role of Fibrates in Primary Biliary Cholangitis

  2019cites this paper
• PEROXISOME ASSEMBLY IN YARROW/A UPOLYTICA PEROXISOME ASSEMBLY IN YARROW/A UPOLYTICA

  2017cites this paper
• Fibrates: Risk Benefits and Role in Treating Dyslipidemias

  2015cites this paper
• Clofibrate in type II hyperlipoproteinemia.

  2009cites this paper
• The Search for Cholesterol-lowering Drugs

  2007cites this paper
• The Treatment of Cerebrovascular Disease With Clofibrate

  2005cites this paper
• Effect of clofibrate on cholesterol metabolism in rats treated with polychlorinated biphenyls

  1986cites this paper
• Comparative hypolipidemic effects of clofibric acid and itanoxone on the metabolism and the distribution of lipids in the crab Pachygrapsus marmora tus (Decapoda, Brachyura)

  1986cites this paper
• Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate.

  1983cites this paper
• Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats

  1981cites this paper
• Biogenesis of peroxisomes and glyoxysomes.

  1980cites this paper
• Peroxisomes and Related Particles in Animal Tissues

  1980cites this paper
• The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.

  1980cites this paper
• [Side effects and drug interactions of lipid-lowering drugs].

  1980cites this paper
• Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug.

  1979cites this paper
• Selective effects of clofibrate on alkaline phosphatase isoenzymes in serum.

  1979cites this paper
• Influence of clofibrate on plasma lecithin: cholesterol acyltransferase (LCAT) activity in rats.

  1979cites this paper
• Drug management of hypercholesterolemia.

  1979cites this paper
• Fatty acid composition of cholesteryl esters in cholesterol-fed rabbits treated with lipid-lowering agent (ethyl 2-(p-chlorophenoxy) isobutyrate).

  1979cites this paper
• Myopathy induced by clofibrate treatment in normolipaemic patients.

  1979cites this paper
• Drug interactions and side effects of hypolipidemic drugs.

  1979cites this paper
• [Drug treatment of primary hyperlipoproteinemia (author's transl)].

  1978cites this paper
• Medikamentöse Behandlung primärer Hyperlipoproteinämien

  1978cites this paper
• Medikamentse Behandlung primrer Hyperlipoproteinmien@@@Drug treatment of primary hyperlipoproteinemia

  1978cites this paper
• Clofibrate retardation of naturally-occurring arteriosclerosis in repeatedly-bred male and female rats.

  1978cites this paper
• Metabolic effects of clofibrate on experimental animals.

  1978cites this paper
• Influence of Sex on Drug Kinetics in Man

  1977cites this paper
• Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.

  1977cites this paper
• Effect of clofibrate on plasma levels of alkaline phosphatase.

  1977cites this paper
• Reduced activity of hepatic microsomal fatty acid chain elongation synthesis in clofibrate-fed rats.

  1977cites this paper
• Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.

  1977cites this paper
• Vitamin K and the oral anticoagulant drugs.

  1976cites this paper
• CHAPTER 4 – Drug Distribution

  1976cites this paper
• A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

  1976cites this paper
• Letter: Reduction of serum alkaline phosphatase and gamma-glutamyl transpeptidase activities by short-term clofibrate.

  1976cites this paper
• Effect of ethyl p-chlorophenoxyisobutyrate on the adrenocortical glucocorticoid function in guinea pigs

  1976cites this paper
• Letter: Reduction of serum alkaline phosphatase and gamma-glutamyl transpeptidase activities by short-term clofibrate.

  1976cites this paper
• Letter: Fetal viability.

  1975cites this paper
• 4 Antihyperlipidaemic Agents

  1975cites this paper
• A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.

  1975cites this paper
• Letter: Reduction of serum-alkaline-phosphatase by clofibrate.

  1975cites this paper
• Impotence in patients treated with clofibrate.

  1975cites this paper
• Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.

  1975cites this paper
• Hypolipidemic Agents

  1975cites this paper
• REDUCTION OF SERUM-ALKALINE- PHOSPHATASE BY CLOFIBRATE

  1975cites this paper
• Antihyperlipidaemic agents.

  1975cites this paper
• [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].

  1974cites this paper
• Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.

  1974cites this paper
• Influence of Clofibrate (Ethyl-4-Chlorophenoxyisobutyrate) on Hepatic Drug Metabolism in Male Rats 1

  1974cites this paper
• Die Langzeitwirkung von Alufibrat bei verschiedenen Hyperlipidämie-Typen

  1974cites this paper
• Halofenate versus clofibrate in the management of true diabetes insipidus.

  1974cites this paper
• Effect of clofibrate on water metabolism in hypothalamic and ADH-resistant diabetes insipidus.

  1973cites this paper
• The Coronary Drug Project: Design, Methods, and Baseline Results

  1973cites this paper
• Drugs and lipid metabolism.

  1973cites this paper
• [Drug interactions with vitamin K antagonists].

  1973cites this paper
• [Lipids during pregnancy and delivery].

  1972cites this paper
• Effect in vitro of clofibrate and trans-1,4-bis-(2-chlorobenzylaminoethyl)-cyclohexane dihydrochloride (AY 9944 ) on respiration and adenosine triphosphatase activity of mouse liver mitochondria.

  1972cites this paper
• The effect of clofibrate on serum and faecal lipids.

  1972cites this paper
• The activity of the different carnitine acyltransferases in the liver of clofibrate-fed rats.

  1972cites this paper
• Agents affecting lipid metabolism. XL. Effect of ethyl chlorophenoxyisobutyrate on liver lipids and serum lipoproteins in rats.

  1971cites this paper
• Long-term treatment of hyperlipidemic patients with clofibrate.

  1971cites this paper
• Experimental approaches to the prophylaxis and treatment of ischaemic heart disease

  1971cites this paper
• Hypolipidemic, uricosuric, and thyroxine‐displacing effects of MK‐185 (halofenate)

  1971cites this paper
• Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopin

  1971cites this paper
• Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man.

  1971cites this paper
• Drug Interactions with Coumarin Anticoagulants

  1971cites this paper
• Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.

  1971cites this paper
• Drug interactions with coumarin anticoagulants. 2.

  1971cites this paper
• Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.

  1971cites this paper
• Effect of clofibrate on plasma lipids of rat and rabbit.

  1970cites this paper
• On the mode of action of lipid-lowering agents. II. In vitro inhibition of acetyl coenzyme A carboxylase by a hypolipidemic drug.

  1970cites this paper
• Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat.

  1970cites this paper
• Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate

  1970cites this paper
• Determinants of the response to oral anticoagulant drugs in man.

  1970cites this paper
• Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease.

  1969cites this paper
• Long‐Term Effects of Clofibrate (Atromid‐S) on Serum Lipids in Man

  1969cites this paper
• Inhibition of hepatic acetyl coenzyme A carboxylase by hypolipidemic agents.

  1969cites this paper
• The effect of clofibrate on the serum triglyceride concentration in normal males fed high-sucrose diets.

  1969cites this paper
• Migraine associated with hyper‐pre‐beta lipoproteinemia

  1969cites this paper
• Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.

  1969cites this paper
• Drug treatment of hyperlipidemia.

  1969cites this paper
• [Therapy of primary hyperlipemias].

  1969cites this paper
• Long-Term Effects ofClofibrate (Atromid-S) on SerumLipids inMan

  1969cites this paper
• Clofibrate-induced changes in the activity of human intestinal enzymes.

  1969cites this paper
• Coronary insufficiency due to secondary hyperlipoproteinemia.

  1969cites this paper
• Appraisal of clofibrate as a hypolipidemic agent.

  1968cites this paper
• Measures to reduce the serum lipid levels in coronary heart disease.

  1968cites this paper
• Dietary and other factors which influence serum lipids.

  1968cites this paper
• Attempted suicide with clofibrate.

  1968cites this paper
• Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).

  1968cites this paper
• Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

  1968cites this paper
• The effects of clofibrate on the metabolism of C14 labeled tripalmitin in the human subject

  1967cites this paper
• The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.

  1967cites this paper
• Clofibrate (Atromid‐S®)

  1967cites this paper
• THE IN VITRO EFFECT OF CLOFIBRATE ON PLATELET AGGREGATION

  1966cites this paper
• Surface uptake of the azo dye Luxol ARN by human platelets.

  1966cites this paper
• The hypocholesterolemic effect of phenyramidol

  1966cites this paper
• Hypolipidemic effect of chlorophenoxyisobutyrate in adult‐onset diabetes mellitus

  1966cites this paper
• TRIAL OF “ATHERAN” AND “ATROMID‐S” IN ATHEROSCLEROSIS

  1966cites this paper